Molecular imaging of amyloidosis: will the heart be the next target after the brain? (Q37970935)

26 August 2017

Molecular imaging of amyloidosis: will the heart be the next target after the brain? (English)

1 reference

26 August 2017

Wengen Chen

1

1 reference

PubMed ID

22193845

26 August 2017

Vasken Dilsizian

series ordinal

2

1 reference

26 August 2017

1 April 2012

1 reference

Current cardiology reports

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

2

1 reference

26 August 2017

226-233

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-011-0239-5

26 August 2017

0 references

cites work

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Cardiac amyloidosis: approaches to diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Molecular mechanism of Thioflavin-T binding to amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Synthesis of 18F-labelled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Micro-imaging of amyloid in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Radioimmunodetection of amyloid deposits in patients with AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Antimyosin Scintigraphy for Detection of Cardiac Amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0239-5

Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection

21 January 2018

1 reference

12 December 2020

99mTc-aprotinin scintigraphy in amyloidosis.

1 reference

12 December 2020

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

1 reference

12 December 2020

Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis

1 reference

12 December 2020

Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis

1 reference

12 December 2020

Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis

1 reference

12 December 2020

Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin

1 reference

12 December 2020

Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy

1 reference

12 December 2020

Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis

1 reference

12 December 2020

Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG

1 reference

12 December 2020

Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation

1 reference

12 December 2020

Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody

1 reference

12 December 2020

Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement

1 reference

12 December 2020

[Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation]

1 reference

12 December 2020

Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability

1 reference

12 December 2020

Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis

1 reference

12 December 2020

10.1007/S11886-011-0239-5

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22193845